Concepedia

Qing He

QH

Statistics

Publications

2

Citations

110

H-Index

2

Active since

2022

Affiliations

Wuhan YZY Biopharma (China)(Current)

Qing He is an author at Wuhan YZY Biopharma (China) specializing in pd-l1 blockade, bispecific antibody combinations, and tumor immunology.

Publications per year

2022–2023

2

Publications

2

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy

Mengke Niu, Ming Yi, Yuze Wu et al. · Journal of Hematology & Oncology · 2023 · 100 citations · Full text

, , +17

Vγ2 x PD-L1, a Bispecific Antibody Targeting Both the Vγ2 TCR and PD-L1, Improves the Anti-Tumor Response of Vγ2Vδ2 T Cell

Rui Yang, Qing He, Hui Zhou et al. · Frontiers in Immunology · 2022 · 10 citations · Full text

, , +17

1–2 of 2